Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1453687 · RNAC

Cartesian Therapeutics, Inc.

Filing with the SEC SEC-reporting company Frederick, MD Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$126M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $130M for the year (2024: −$77.4M).
  • Revenue downRevenue fell from $38.9M in 2024 to $2.8M in 2025 (93% lower).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$2.8M$38.9M
Net income (loss)−$130M−$77.4M
Total assets$296M$435M
Total liabilities$423M$442M
Stockholders’ equity−$126M−$6.8M
Cash and equivalents$125M$213M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Cartesian Therapeutics, Inc.
Formerly: Selecta Biosciences Inc
CIK
0001453687
Tickers
RNAC
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Frederick, Maryland
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 5, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2026 · filing · edition of Nov 5, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 6, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.03, 3.02, 5.02, 7.01, 9.01 · filed May 26, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 30, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed Apr 30, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 30, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 9, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 9, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.05, 7.01, 9.01 · filed Dec 18, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 7.01, 9.01 · filed Oct 30, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 21, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 8, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 7, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 8, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 29, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 13, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Aug 2, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 17, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01 · filed Jul 2, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 17, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 8, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Apr 1, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 7, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 7, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 7.01, 9.01 · filed Mar 5, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 19, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Dec 1, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 27, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 22, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 22, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Nov 13, 2023 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Nov 13, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 13, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 8.01, 9.01 · filed Oct 31, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 25, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 17, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 17, 2023 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 4, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 2, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 9, 2023 · filing